Arsanis, Inc. Loan Agreements
8 Contracts & Agreements
- Amendment No. 2 to Amended and Restated Loan and Security Agreement, dated as of December 21, 2020, by and among X4 Pharmaceuticals, Inc., each of its Qualified Subsidiaries... (Filed With SEC on December 23, 2020)
- Amendment No. 1 to Loan and Security Agreement, dated March 13, 2020, by and between X4 Pharmaceuticals, Inc. and Hercules Capital, Inc (Filed With SEC on March 17, 2020)
- Amended and Restated Loan and Security Agreement, dated as of June 27, 2019, by and among X4 Pharmaceuticals, Inc., X4 Therapeutics, Inc., Hercules Capital, Inc. and Hercules... (Filed With SEC on June 28, 2019)
- Amendment No. 1 to Loan and Security Agreement, dated as of December 11, 2018, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Hercules Capital, Inc (Filed With SEC on March 13, 2019)
- Loan and Security Agreement, dated as of October 19, 2018, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Hercules Capital, Inc (Filed With SEC on March 13, 2019)
- Loan and Security Agreement, dated as of December 7, 2012, by and between the Registrant and Silicon Valley Bank, as amended (Filed With SEC on October 20, 2017)
- Amendment No. 4 to Amended and Restated Loan and Security Agreement, dated as of June 30, 2022, by and among X4 Pharmaceuticals, Inc., each of its Qualified Subsidiaries... (Filed With SEC on July 1, 2022)
- Amendment No. 3 to Amended and Restated Loan and Security Agreement, dated as of February 9, 2022, by and among X4 Pharmaceuticals, Inc., each of its Qualified Subsidiaries... (Filed With SEC on February 9, 2022)
